Recruiting studies: Schizoaffective Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates
Phase 4 · 1 location(s) · Corporal Michael J. Crescenz VA Medical Center · NCT03495024 MicroRNAs as Biomarkers in First Episode Schizophrenia
NA · 1 location(s) · Northwell Health · NCT07703670 Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
Phase 1 · 5 location(s) · BioXcel Therapeutics Inc · NCT05025605 Examining the Efficacy of a Virtual Reality Cognitive Remediation Program for People Living With Psychosis
NA · 1 location(s) · The Royal Ottawa Mental Health Centre · NCT05973110 Low Amplitude Pulse Seizure Therapy Versus Standard Ultra-Brief Right Unilateral Electroconvulsive Therapy
Phase 2/Phase 3 · 1 location(s) · Michigan State University · NCT06529029 Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia
Phase 4 · 1 location(s) · University of Massachusetts, Worcester · NCT06174116 Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.
Phase 3 · 1 location(s) · Louisiana State University Health Sciences Center Shreveport · NCT06482554 Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder
NA · 1 location(s) · Mclean Hospital · NCT06221852 Non-invasive Brain Stimulation Using Tdcs of the Third (of Many) Visual Pathways
NA · 1 location(s) · Nathan Kline Institute for Psychiatric Research · NCT07469384 Enhancing Rehabilitation for Veterans With Serious Mental Illness
NA · 1 location(s) · VA Office of Research and Development · NCT06586164 Cerebellar Modulation of Cognition in Psychosis
NA · 2 location(s) · Mclean Hospital · NCT06107764 Database Registry for Neural Network Biomarkers in Psychosis
Phase N/A · 1 location(s) · University of Texas Southwestern Medical Center · NCT01409109 Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia
Phase 1/Phase 2 · 1 location(s) · Vishwajit Nimgaonkar, MD PhD · NCT03794076 Magnetic Seizure Therapy for Schizophrenia - Trial
NA · 2 location(s) · Centre for Addiction and Mental Health · NCT06672588 Prediction and Intervention Effect of Rehabilitation Status for Severe Mental Disorder Patients Based on Multimodal Anal
NA · 1 location(s) · Shanghai Mental Health Center · NCT06904079 iTBS to Enhance Social Cognition in People With Psychosis
NA · 1 location(s) · Northwell Health · NCT06118268 40 Hz Visual Stimulation as an Intervention in Schizophrenia
NA · 1 location(s) · Technical University of Munich · NCT06907420 Anticholinergic Deprescription in Schizophrenia
Phase 4 · 1 location(s) · Deepak K. Sarpal, M.D. · NCT06562608 Neurotransmitters in Treatment Resistant Schizophrenia Patients With add-on Sodium Benzoate
Phase 2 · 1 location(s) · National Cheng-Kung University Hospital · NCT06340789 The Effect of Structured Medical Nutrition Therapy on Systemic Inflammation Index in Patients With Schizophrenia Receivi
NA · 1 location(s) · DINA KEUMALA SARI · NCT07696000 Acetazolamide for Treatment Resistant Schizophrenia
Phase 1/Phase 2 · 2 location(s) · Vishwajit Nimgaonkar, MD PhD · NCT04887792 Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness (R33)
NA · 1 location(s) · University of California, San Diego · NCT06865937 TOPUS - Testing an Implemented Intervention to Reduce Duration of Untreated Psychosis
Phase N/A · 2 location(s) · Mental Health Centre Copenhagen, Bispebjerg and Frederiksber · NCT07716969 Synergy Between Physical Activity and Outdoor Green Environments to Reduce the Intensity of Negative Symptoms in Schizop
NA · 1 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT07058389 A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Sympt
Phase 4 · 22 location(s) · Neurocrine Biosciences · NCT07105111 Synbiotic Compound to Reduce Symptoms of Schizophrenia
Phase 2 · 1 location(s) · Sheppard Pratt Health System · NCT04226898 Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode
NA · 1 location(s) · University of California, Los Angeles · NCT05890183 Visual Perception in Schizophrenia
NA · 1 location(s) · University of Rochester · NCT06911931 Transition Care for FEP
Phase N/A · 2 location(s) · University of Chicago · NCT07713849 Accelerated Transcranial Magnetic Stimulation for People With Schizophrenia Treated With Clozapine
NA · 1 location(s) · Deepak K. Sarpal, M.D. · NCT06003036

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.